Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR4F4 Inhibitors

OR4F4 Inhibitors consists of a diverse group of compounds that can modulate the activity of OR4F4, an olfactory receptor. These inhibitors are designed to target the complex mechanisms of olfactory perception by interfering with the receptor's ability to detect and respond to odorants or by modulating the subsequent signal transduction pathways. The primary approach of these inhibitors is to prevent the activation of OR4F4 by odorants, which involves either directly competing with odorant molecules for binding sites on the receptor or altering the receptor's conformation to reduce its affinity for odorants. By blocking the initial interaction between OR4F4 and odorant molecules, these inhibitors can effectively reduce or eliminate the receptor's ability to initiate a signal in response to specific smells. This method capitalizes on the specificity of olfactory receptors for their ligands, offering a targeted approach to modulating olfactory signaling. Additionally, these inhibitors encompass compounds that affect the downstream signaling mechanisms associated with OR4F4 activation. Given that OR4F4 is a G-protein coupled receptor (GPCR), the signal transduction pathways it initiates are complex and involve several cellular components, including G-proteins and various secondary messengers. The inhibitors in this class can interfere with these pathways at multiple levels, such as by inhibiting G-protein activation or by modulating the production of secondary messengers like cAMP. This approach allows for the modulation of the receptor's signaling efficiency and can have a profound impact on the overall olfactory response. By targeting both the receptor-ligand interaction and the downstream signaling cascade, OR4F4 inhibitors offer a comprehensive strategy for modulating olfactory perception at the molecular level. In essence, the OR4F4 inhibitors represent a sophisticated approach to understanding and modulating the sense of smell. Their development and study provide valuable insights into the intricate workings of olfactory receptors and their associated signaling pathways. These inhibitors are not only tools for probing the molecular basis of olfaction but also serve as a testament to the complexity of sensory perception and the nuanced strategies required to modulate it at the cellular level.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Suramin sodium

129-46-4sc-507209
sc-507209F
sc-507209A
sc-507209B
sc-507209C
sc-507209D
sc-507209E
50 mg
100 mg
250 mg
1 g
10 g
25 g
50 g
$149.00
$210.00
$714.00
$2550.00
$10750.00
$21410.00
$40290.00
5
(1)

GPCR antagonist that could potentially inhibit OR4F4 by preventing G-protein activation and subsequent signaling.

Losartan

114798-26-4sc-353662
100 mg
$127.00
18
(1)

Angiotensin II receptor antagonist that could potentially inhibit OR4F4 by affecting similar GPCR signaling pathways.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$122.00
$235.00
$520.00
$979.00
$1500.00
2
(1)

Non-selective beta-adrenergic blocker that could potentially modulate GPCR signaling pathways, thus inhibiting OR4F4.

Ketoconazole

65277-42-1sc-200496
sc-200496A
50 mg
500 mg
$62.00
$260.00
21
(1)

CYP3A4 inhibitor that could potentially affect metabolic pathways involved in GPCR signaling, thus inhibiting OR4F4.

Itraconazole

84625-61-6sc-205724
sc-205724A
50 mg
100 mg
$76.00
$139.00
23
(1)

CYP3A4 inhibitor that could potentially alter GPCR-associated metabolic pathways, thus inhibiting OR4F4.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Adenylyl cyclase activator that could potentially modulate the cAMP pathway often involved in GPCR signaling, thus inhibiting OR4F4.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$442.00
3
(1)

G-protein inhibitor that could prevent G-protein coupling and signaling, thus inhibiting OR4F4.

AMI-1, sodium salt

20324-87-2sc-205928
sc-205928A
5 mg
25 mg
$112.00
$390.00
2
(1)

Adenylyl cyclase inhibitor that could modulate cAMP production, impacting GPCR signaling and potentially inhibiting OR4F4.